Mahana Therapeutics develops digital treatments for people living with chronic health conditions. Mahana Therapeutics digital treatments are designed to provide physical and psychological support that will be clinically proven to help patients feel better. Mahana Therapeutics was established on January 1, 2018 by Robert Paull and Simon Levy in San Francisco, California.

CureApp is a digital health startup.The firm is one of the leading players in the medical app vertical under the theme of “app exhibits therapeutic effects against diseases” and launched a nicotine addiction treatment app in February 2015, which was jointly developed with Division of Pulmonary Medicine, Keio University’s School of Medicine. It is currently conducting clinical trials in many locations.

BioTrak is digital therapeutics platform company with smartphone products which deliver evidence-based, preventative treatment of stress-related disorders such as migraine, multiple sclerosis, depression, chronic pain, and anxiety. The first of a series of products is Ease: Headache and Migraine™, which was launched Q1’ 19. Three (3) billion people worldwide suffer from severe tension-type headaches and migraine. Ease, which delivers clinically-tested behavioral interventions on a mobile platform, is superior in clinical effectiveness, safety, cost, and convenience compared to the most advanced migraine drugs. Ease is positioned to be used either alone or adjunctively with conventional drug therapies. Ease: Headache & Migraine™ is digital therapeutic app that delivers clinically-proven, effective behavioral therapy. Ease has been shown to be as effective as in-office treatment, resulting in 60% reduction in headache frequency and disability. Ease is a brand new approach to addressing the severely unmet need for a scalable, affordable, safe and effective treatment option for the estimated 3 billion people who suffer from tension headache and migraine worldwide.

Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Provides an application to reduce the impact of mental health conditions and diseases with science

National Center of Neurology and Psychiatry provides treatment and prevention therapy for mental, nervous, and developmental disorders.

Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Zansors is a developer of a cloud-based platform designed to share patient-created data with health systems. The company's platform utilizes direct standard cloud protocol to allow sensors and apps to send data to medical institutions from evidence-based applications via health system's electronic health record, enabling physicians to collect close to real time and interpret in an evidence-based environment.

Sonova AG engages in the development and marketing of hearing care solutions. Its products include Hearing instruments, Cochlear implants. The firm also provides audiological services. The company was founded on July 4, 1947 and is headquartered in Stäfa, Switzerland.

Biomimetics Sympathies is a bio technical firm that research on the medicine and create products and regenerative medicine.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Alpha recruits the very best minds committed to shaping a positive global future. Our pioneers chart new paths across unknown technology and business territories. We constantly push boundaries and think outside the norm to turn our creative visions into reality. The Alpha culture is built upon trust and empowerment, to lead and collaborate by thinking big and dreaming even bigger, all while maintaining high standards of rigor, honesty, and integrity. A lively spirit of play and exploration abounds, wherein all Alpha pioneers are challenged to remain curious, daring and unpredictable. Alpha pioneers learn to develop a close relationship with failure as a tool of empowerment. Big failures lead to big lessons. Quicker failures lead to faster learning and growth. At Alpha, failure isn't something to be ashamed of, but rather embraced as an essential tool for rapid progress. Failures that teach us important lessons are celebrated and become important lessons and components of the company and its culture.

Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development.

Fitbit inspires people to exercise more, eat better, and live healthier lifestyles. The company is developing an ultra-compact wireless wearable sensor, called the Fitbit Tracker, that automatically tracks data about a person's activities, such as calories burned, sleep quality, steps, and distance. The Fitbit Tracker collects activity data automatically while it is worn by the user all day. The collected data is wirelessly uploaded to a website where the wearer can see their data and track their progress toward personal goals. The website provides a motivational interface where users can share their progress, compare themselves against similar people and work toward virtual goals with their friends, family, and co-workers. On the website, users can also manually log nutrition, weight, and other health information in order to gain a complete picture of their health. Fitbit makes it easy to achieve a healthy lifestyle by automating the collection of health data and providing a motivating and entertaining user interface.

Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA.

doc.ai is developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building. The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.

Olive Union Co. Ltd. engages in the development of medical equipment. Its products include Olive Hearing Aid which is a smart sound Bluetooth earpiece device. The company was founded by Myeong-Geun, Song on June 29, 2016 and is headquartered in Seoul Korea.